Personal information

Activities

Education and qualifications (3)

University of California, San Francisco: San Francisco, US

2021-09-01 to present | PhD Student (Pharmaceutical Sciences and Pharmacogenomics)
Education
Source: Self-asserted source
Ava Xu

Chapman University School of Pharmacy: Irvine, CA, US

2018-09-01 to 2021-05-18 | Doctor of Pharmacy
Education
Source: Self-asserted source
Ava Xu

Chapman University: Orange, California, US

2016-09-01 to 2018-05-18 | Pre-Pharmacy (School of Pharmacy )
Education
Source: Self-asserted source
Ava Xu

Works (2)

Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine
2024-12-01 | Journal article
Contributors: Ava Y. Xu; Gustavo E. Velásquez; Nan Zhang; Vincent K. Chang; Patrick P. J. Phillips; Payam Nahid; Susan E. Dorman; Ekaterina V. Kurbatova; William C. Whitworth; Erin Sizemore et al.
Source: check_circle
Crossref

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

Clinical Infectious Diseases
2024-06-14 | Journal article
Contributors: Huy X Ngo; Ava Y Xu; Gustavo E Velásquez; Nan Zhang; Vincent K Chang; Ekaterina V Kurbatova; William C Whitworth; Erin Sizemore; Kia Bryant; Wendy Carr et al.
Source: check_circle
Crossref